|
Sign In to gain access to subscriptions and/or personal tools.
|
Child and learning disability psychopharmacology
In January 1997, the British Association for Psychopharmacology convened a Round Table meeting to look at issues surrounding the prescription of psychotropic drugs to children or individuals with learning disabilities. This followed reports in the UK media about increasing rates of prescription to children with attention deficit hyperactivity disorder (ADHD) and children who are depressed as well as concerns regarding the prescription of psychotropic drugs to both children and adults with learning disabilities. The participants included both clinical and basic scientists, psychiatrists and psychologists, as well as regulators and representatives of the pharmaceutical industry and they were drawn from the UK, the United States, Canada, Holland, France and Germany. The brief was to consider the evidence in favour of prescribing for individuals with learning disabilities or children with obsessive-compulsive disorder, schizophrenia, depression or ADHD and the basis on which prescribing could take place in the absence of clinical trial evidence of efficacy drawn from the populations in question, where prescribing is effectively off label or outside the remit of a medicine's product licence or sometimes must take place in the face of data sheet disclaimers that it is contraindicated.
Journal of Psychopharmacology, Vol. 11, No. 4,
291-294 (1997)
DOI: 10.1177/026988119701100402
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
D. Healy
Trussed in Evidence? Ambiguities at the Interface between Clinical Evidence and Clinical Practice
Transcultural Psychiatry,
March 1, 2009;
46(1):
16 - 37.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. S. Baldwin and N. Kosky
Off-label prescribing in psychiatric practice
Adv. Psychiatr. Treat.,
November 1, 2007;
13(6):
414 - 422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F. Clark
Incidences of New Prescribing by British Child and Adolescent Psychiatrists: a Prospective Study Over 12 Months
J Psychopharmacol,
March 1, 2004;
18(1):
115 - 120.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Lowe-Ponsford and D. Baldwin
Off-label prescribing by psychiatrists
Psychiatr. Bull.,
November 1, 2000;
24(11):
415 - 417.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. Quinn
Monitoring of carbamazepine and valproate prescribing practice
Psychiatr. Bull.,
September 1, 2000;
24(9):
352 - 352.
[Full Text]
|
|
|
|
|
|
|
D. Wilkinson
Loss of anxiety and increased aggression in a 15-year-old boy taking fluoxetine
J Psychopharmacol,
July 1, 1999;
13(4):
420 - 420.
[PDF]
|
|
|
|
|
